الفهرس | Only 14 pages are availabe for public view |
Abstract Critical illness is often characterized by hyperglycemia and insulin resistance. Hyperglycemia may have detrimental effects at the cellular level and contribute to organ failure, morbidity and ultimately death. This was most pronounced in patients with a demonstrable septic focus. Recent publications demonstrated the beneficial effects of strictly maintaining normoglycemia in ICU patients by administration of intensive insulin therapy. A significant reduction in mortality of ICU patients was observed, particularly of those with prolonged critical illness. Furthermore, intensive insulin therapy was able to protect against acute renal failure, the development of critical illness, polyneuropathy, also partially counteracted the deranged serum lipid profile and impaired immunity seen in critically ill patients. Microalbuminuria is a common finding in critically ill patients, where it has shown promise not only as a predictor of organ failure and vasopressor requirement, but also of mortality, faring better than Acute Physiological and chronic Health Evaluation (APACHE) II score and Sequential Organ Function Assessment (SOFA) score. This research studied the effect of the application of tight glycemic control protocol (group I, 30 patients) on microalbuminuria and organ failure in severe sepsis, with conventional glycemic control (group II, 30 patients) during the first 7 days of their stay in ICU. All patients were continuously monitored for blood glucose level, vital signs and SOFA score. Results showed less morbidity in the tight glycemic control group. This was confirmed by reduction in SOFA score, microalbuminuria and ICU stay in TGC group. from our results, we concluded that application of tight glycemic control protocols using continuous intravenous insulin infusion could be a safe, cheap and effective therapeutic modality in reducing ICU morbidity in severe sepsis and there are positive correlation between MACR and SOFA score which led us to focus on microalbuminuria as an early marker in severe sepsis. |